Navigation Links
intendiX - Communication by Thoughts: First Patient-Ready System on the Market
Date:11/9/2009

SCHIEDLBERG, Austria, November 9 /PRNewswire/ -- For more than 20 years researchers all over the world have been working on the development of a Brain-Computer Interface (BCI). This is a direct communication channel between the brain and a computer. Such a system enables completely paralyzed patients to communicate or to control devices in their environment just by mental activity. During the last years some patients have been supervised by the researchers themselves to use such BCI systems in daily life. The Austrian company g.tec medical engineering GmbH now brings the first patient-ready BCI on the market. The EEG-based spelling system is called intendiX and enables the user to select keys from a matrix just by paying attention to a target symbol on the screen.

In this way the patient can write messages or commands. intendiX can speak the written text, print it or copy it into an e-mail message. The system is designed to be used without the assistance of a technician and can be installed and operated by the caregiver. For most users intendiX works pretty fine after only a few minutes of training. For paralyzed patients the system has to be tried and evaluated in every specific case. Therefore g.tec provides systems for rent to patients and hospitals. g.tec is a worldwide provider of hard- and software for biosignal and BCI research and is actively cooperating with worldwide leading research-groups for many years.

    Please visit http://www.intendiX.com to see the system.
    Information about BCI:
    http://www.gtec.at/products/g.BCIsys/bci.htm
    Download press-photos at:
    http://www.gtec.at/Press


    Contact:


'/>"/>
SOURCE g.tec medical engineering GmbH
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Investor Relations Firm Access IR/PR and The Communications Strategy Group Announce Strategic Alliance
2. Nanophotonic devices could revolutionize the telecommunications industry
3. Leaders in Health Literacy Recognized by the Partnership for Clear Health Communication at the National Patient Safety Foundation
4. Senetek PLC Announces New Investor Communication Hotline
5. Informed Medical Communications Appoints New Senior Manager, Strategic Operations
6. The Medical Affairs Company Expands Its Medical Communications Division
7. Informed Medical Communications Appoints New Vice President, Information Technology
8. DaVita Wins Gold in International Marketing and Communications Competition
9. P2R Associates Presented with Eight MarCom Awards for Client Strategic Communication Programs
10. Advanced Technologies and Wireless Telecommunications Enhance Care and Medical Training at the Ryder Trauma Center in Miami
11. First tunable, noiseless amplifier may boost quantum computing, communications

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., November 19 AFFiRiS AG will focu...andidate at an unexpectedly early,stage of develop...er into,Phase II clinical trial early in 2010. Thi...completion of two Phase I trials with the candidat...ion on the first interim,analysis of the secondary...
(Date:11/18/2009)...ka-dotted postage stamp that can sniff out poisono...s. , As reported in the Sept. 13 issue of the jo...team at the University of Illinois have developed ...xic industrial chemicals (TICs) that is simple, fa.... This sensor array could be useful in detecting ...
(Date:11/18/2009)... Masimo (Nasdaq: MASI...ure-Through Motion and Low-Perfusion pulse oximetr...., one of the largest healthcare Group Purchasing ...year purchasing agreement for "gold standard" Masi...ers preferred contract pricing to Uni.H.A.,s 53 me...
(Date:11/18/2009)...Corporation and SwitchGear Genomics announce a nov...ons. , Madison, WI, USA (...d SwitchGear Genomics announce a novel method for ...f a study using the HaloCHIP™ System and hig...ty to correlate DNA binding events to transcriptio...
Breaking Biology Technology:AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2
...EC CITY, Feb. 12 /PRNewswire-FirstCall/ - AEterna ... biopharmaceutical company focused on,endocrine th...AEZS-108, a,luteinizing hormone-releasing hormone ... in its Phase 2 trial in gynaecological cancers fo...07. This open-label,non-comparative multi-center P...
...ad Clinical Program and Two Clinical Candidates Fe...aven,biotechnologies, inc., a privately held compa...oclonal antibody therapeutics (MAbs) for cancer,an...entation at the meeting,of American Association fo... 12-16, 2008., "We are pleased to have this oppor...
...CARLOS, Calif., Feb. 12 Nektar,Therapeutics (Nasd...ed to,complete its transition from a drug delivery...nt organization. The restructuring will,streamline... strengthen,decision-making and execution within t...nto a world-class drug development company,and the...
Other Biology Technology:AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers 2AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers 3AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers 4Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations 2Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations 3Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization 2Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization 3
(Date:11/20/2009)... origin of biological molecules like RNA and DNA i...go from simple precursors. Now, in a study appeari...econstructed one of the earliest evolutionary step...al subunits using nothing but warm water. , Man...t biological molecules present, before DNA and pro...
(Date:11/20/2009)...009 - Bacteria possess an ingenious mechanism for ... of the cell. This is the new finding of a team of...life sciences research institute in Flanders, Belg...The scientists made this discovery by modifying th...i . By means of this model organism, they have unc...
(Date:11/20/2009)...gy Research Center (ERC) has been awarded a grant ...p methods of recovering and reusing the heat that ...ompression process in a carbon capture system. The...bon capture and sequestration, or storage (CCS), a...s, emitted into the atmosphere by coal-fired power...
Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3New vaccine delivery may be more effective against measles 58417 1New vaccine delivery may be more effective against measles 58417 2Van Andel Institute researchers find gene that could lead to new therapies for bone marrow disease 58414 1Van Andel Institute researchers find gene that could lead to new therapies for bone marrow disease 58414 2Hyenas cooperate problem solve better than primates 10138 1Hyenas cooperate problem solve better than primates 10138 2Hyenas cooperate problem solve better than primates 10138 3
..., A blue curing light used to harden dental fillin... Georgia researchers say. , "The light sends wave...ch triggers hardening," says Alpesh Patel, a risin... produce free radicals that activate the catalyst .... In oral cancer cells, though, those radicals cau...
... No-take marine reserves, in which fishing is comp... the fish species most prized by commercial and re...alia,s Great Barrier Reef published in the June 24...ation. , The researchers found in most cases that...creational hook-and-line fisheries in Australiabou...
... Bolton Landing, N.Y. Prior to the federal Clean ...ased into the air throughout the Midwestern and Ea...mful chemicals came right back down to earth in th...cludes nitric and sulfuric acid. , Researchers ha... the diversity of plant and animal communities in ...
Other Biology News:Blue light used to harden tooth fillings stunts tumor growth 2Exploited fish make rapid comeback in world's largest no-take marine reserve network 2Database shows effects of acid rain on microorganisms in Adirondack Lakes 2Database shows effects of acid rain on microorganisms in Adirondack Lakes 3
...Screening Sets contain the basic components and pr...ich ELISA plates for quantitation of a specific pr...ry Screening Set contains Coating and Detection An...ards), Streptavidin-HRP, TMB Substrate Solution (o...
Organic Acid Analysis Standard, 6 vials from Bio-Rad
...VUE is a particle shape and size analyzer offering...he utmost simplicity in mind. It is comprised of a...an optical bench. The system is completely compute...pgrade for different applications such as dry or w...
Neurological Profile from Novascreen-a Caliper Life Sciences Company
Biology Products: